Federal rules and notices on 340B

38 rules, proposed rules and notices published in the Federal Register since January 2025 name the 340B program. Here is what each one does about 340B, the day comments close, the day it takes effect, and where to read it.

Dates ahead

November 2026

  • Comments close91 FR 60568

    Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards

    Centers for Medicare & Medicaid ServicesFederal Register

  • Takes effect91 FR 62936

    Global Benchmark for Efficient Drug Pricing (GLOBE) Model

    Centers for Medicare & Medicaid ServicesFederal Register

December 2026

  • Comments close91 FR 66408

    Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026

    Centers for Medicare & Medicaid ServicesFederal Register

January 2027

  • Takes effect91 FR 48883

    Notice Regarding 340B Rebate Model Pilot Program

    Health Resources and Services AdministrationFederal Register

  • Date set by a notice91 FR 62936

    The GLOBE Model begins, with drug makers' voluntary price data

    Global Benchmark for Efficient Drug Pricing (GLOBE) Model

    Centers for Medicare & Medicaid ServicesFederal Register

  • Takes effect91 FR 70284

    Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

    Centers for Medicare & Medicaid ServicesFederal Register

  • Takes effect91 FR 70992

    Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

    Centers for Medicare & Medicaid ServicesFederal Register

  • Comments close91 FR 70284

    Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

    Centers for Medicare & Medicaid ServicesFederal Register

April 2027

  • Date set by a notice91 FR 62936

    The GLOBE Model's first performance year begins

    Global Benchmark for Efficient Drug Pricing (GLOBE) Model

    Centers for Medicare & Medicaid ServicesFederal Register

September 2027

  • Date set by a notice91 FR 70992

    Covered entities' first required Part D 340B claim data, for January to June 2027, is due

    Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

    Centers for Medicare & Medicaid ServicesFederal Register

April 2028

  • Date set by a notice91 FR 48883

    The day by which the agency says it will publish its evaluation of the rebate pilot's first year

    Notice Regarding 340B Rebate Model Pilot Program

    Health Resources and Services AdministrationFederal Register

About 340B

12 documents, newest first

  • About 340B
  • Notice

91 FR 48883Notice Regarding 340B Rebate Model Pilot Program

Opens a revised 340B Rebate Model Pilot Program. From January 1, 2027, drug makers with an approved plan may give the 340B price as a rebate after the sale, not as a discount up front, on the drugs selected for Medicare price negotiation for 2026 and 2027.

Agency
Health Resources and Services Administration
Published
3 August 2026
Takes effect
1 January 2027

Other days it sets

  • Drug makers' plans for the rebate pilot were due
  • The day by which the agency said it would approve drug makers' plans for the rebate pilot, if any
  • The day by which the agency says it will publish its evaluation of the rebate pilot's first year
  • About 340B
  • Notice

91 FR 37121340B Rebate Model Pilot Program Application, Implementation, and Evaluation, Correction

Corrects the June 15, 2026 notice on the rebate pilot's data collection. The total number of responses changes from 793,080 to 793,091 to include the 11 drug maker plan submissions.

Agency
Health Resources and Services Administration
Published
22 June 2026
  • About 340B
  • Notice

91 FR 35989Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW

Says the rebate pilot's data collection was sent to the Office of Management and Budget for approval, and opens 30 days for comments. It answers the comments on burden made on the earlier 60-day notice.

Agency
Health Resources and Services Administration
Published
15 June 2026
Comments closed
15 July 2026
  • About 340B
  • Notice

91 FR 9632Request for Information: 340B Rebate Model Pilot Program Extension

Extends the comment period on the February 17, 2026 request for information about a 340B rebate pilot from 30 days to 60 days, so that comments are due April 20, 2026.

Agency
Health Resources and Services Administration
Published
26 February 2026
Comments closed
20 April 2026
  • About 340B
  • Notice

91 FR 9632Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW

Asks for comments on a new data collection for a possible 340B rebate pilot: drug makers' plans, their monthly reports, and claim data from covered entities. It replaces an emergency-cleared collection that the agency ended.

Agency
Health Resources and Services Administration
Published
26 February 2026
Comments closed
27 April 2026
  • About 340B
  • Notice

91 FR 7287Request for Information: 340B Rebate Model Pilot Program

Asks the public whether the agency should use a rebate model for 340B and how to run one, including costs, payment timing, denials, data and duplicate discounts. It says the 2025 pilot was paused after a court order of December 29, 2025.

Agency
Health Resources and Services Administration
Published
17 February 2026
Comments closed
19 March 2026
  • About 340B
  • Notice

91 FR 714Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program, OMB No. 0915-0327-Revision

Sends a revision of the 340B enrollment and recertification forms to the Office of Management and Budget. New items are collected: grant papers from sexually transmitted disease and tuberculosis grantees, the Title X assistance period, and the Tribal agreement number.

Agency
Health Resources and Services Administration
Published
8 January 2026
Comments closed
9 February 2026
  • About 340B
  • Notice

90 FR 44197Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-0111-Extension

Asks for comments, over 60 days, on continuing the 2025 rebate pilot's data collection: drug makers' plans, monthly reports, and the claim data covered entities send to ask for rebates. It says emergency clearance was given on August 26, 2025.

Agency
Health Resources and Services Administration
Published
12 September 2025
Comments closed
12 November 2025
  • About 340B
  • Notice

90 FR 38165340B Program Notice: Application Process for the 340B Rebate Model Pilot Program; Correction

Republishes, as a correction, the August 1, 2025 notice that opened the first 340B rebate pilot. It moves the comment deadline to September 8, 2025 and fills in the docket number. A court set that pilot aside on February 10, 2026.

Agency
Health Resources and Services Administration
Published
7 August 2025
Comments closed
8 September 2025
  • About 340B
  • Notice

90 FR 38167Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program, OMB No. 0915-0327-Revision

Proposes revising the 340B enrollment and recertification forms, and takes comments until October 6, 2025. New items would be collected: grant papers from sexually transmitted disease and tuberculosis grantees, the Title X assistance period, and the Tribal agreement number.

Agency
Health Resources and Services Administration
Published
7 August 2025
Comments closed
6 October 2025
  • About 340B
  • Notice

90 FR 36163340B Program Notice: Application Process for the 340B Rebate Model Pilot Program

Opens the first 340B rebate pilot. Drug makers with Medicare negotiation agreements for 2026 could apply to pay rebates, not discounts up front, on selected drugs from January 1, 2026. A court set this notice aside on February 10, 2026.

Agency
Health Resources and Services Administration
Published
1 August 2025
Comments closed
2 September 2025
  • About 340B
  • Notice

90 FR 3881Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; 340B Drug Pricing Program; Initiation of the Administrative Dispute Resolution Process

Sends a data collection to the Office of Management and Budget for the papers a covered entity or drug maker files to start a 340B Administrative Dispute Resolution claim, with 30 days for comments.

Agency
Health Resources and Services Administration
Published
15 January 2025
Comments closed
14 February 2025

With a part on 340B

15 documents, newest first

  • Has a part on 340B
  • Final rule

91 FR 70992Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Requires 340B covered entities to report Medicare Part D 340B claim data every quarter to a 340B repository run by the Centers for Medicare & Medicaid Services, for claims from January 1, 2027. The first required submission is due September 30, 2027.

Agency
Centers for Medicare & Medicaid Services
Published
9 November 2026
Takes effect
1 January 2027
Docket
CMS-1848-F

Other days it sets

  • Covered entities' first required Part D 340B claim data, for January to June 2027, is due
Where it names 340B: 91 FR 70992

… data are unavailable and the calculation of the Part D rebate amount in such instances; modifies the methodology finalized in the CY 2026 PFS final rule to account for 340B-eligible units for AIDS Drug Assistance Program (ADAP) clients for the applicable period beginning October 1, 2025; and requires Medicare providers and suppliers that …

From the document’s text. It names 340B 800 times.
  • Has a part on 340B
  • Final rule
  • Open for comment

91 FR 70284Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

Sets Medicare hospital outpatient payment for drugs bought under 340B at average sales price minus 28 percent for 2027, where minus 33.4 percent had been proposed. Rural sole community hospitals, children's hospitals and the cancer hospitals paid outside the prospective payment system are exempt. Payments for other services at hospitals subject to the 340B remedy offset are reduced by 2.0 percentage points.

Agency
Centers for Medicare & Medicaid Services
Published
6 November 2026
Comments close
4 January 2027
Takes effect
1 January 2027
Docket
CMS-1850-FC
Where it names 340B: 91 FR 70284

… outpatient quality reporting requirements by applying a reporting factor of 0.9804 to the OPPS payments and copayments for all applicable services. Under the final 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 2.0 percentage points. ASC Payment Update: For CYs 2019 through …

From the document’s text. It names 340B 841 times.
  • Has a part on 340B
  • Proposed rule
  • Open for comment

91 FR 66408Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026

Would require pharmacy benefit managers' reports to Medicare Part D plans to include a list of the covered drugs that are subject to a 340B agreement with a covered entity, where the manager or an affiliate has a contract or other arrangement with that entity.

Agency
Centers for Medicare & Medicaid Services
Published
20 October 2026
Comments close
15 December 2026
Docket
CMS-4214-P
Where it names 340B: 91 FR 66408

… supply chain--including pharmacy spread pricing, retention of a portion of the rebate negotiated with the pharmaceutical manufacturer, and increasing ownership of 340B contract pharmacies--is often not transparent to health plans and may contribute to high drug prices.\13\ Because PBM compensation is often linked to the price of the …

From the document’s text. It names 340B 3 times.
  • Has a part on 340B
  • Final rule

91 FR 62936Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Sets up the GLOBE Model, a Medicare Part B drug rebate test, and leaves 340B units out of its rebate count. It keeps the existing 340B claims modifier, TB, to find those units and says 340B itself, including how its price is calculated, is outside the model.

Agency
Centers for Medicare & Medicaid Services
Published
2 October 2026
Takes effect
30 November 2026
Docket
CMS-5545-F

Other days it sets

  • The GLOBE Model begins, with drug makers' voluntary price data
  • The GLOBE Model's first performance year begins
Where it names 340B: 91 FR 62936

… and may be more likely to experience shortages. Several commenters stated that the Negotiation Program, the Working Families Tax Cuts Act (Pub. L. 119-21), and the 340B Drug Pricing Program (section 340B of the Public Health Services Act) include provisions for orphan drug exclusions and that the 2020 Most Favored Nation (MFN) Model …

From the document’s text. It names 340B 64 times.
  • Has a part on 340B
  • Proposed rule
  • Open for comment

91 FR 60568Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards

One question in this request for information is about 340B: it asks what standard Medicare Part D pharmacy contract terms say about dispensing to 340B patients, and how plan sponsors decide that a claim is for a 340B patient.

Agency
Centers for Medicare & Medicaid Services
Published
24 September 2026
Comments close
23 November 2026
Docket
CMS-4217-NC
Where it names 340B: 91 FR 60568

… (AI) with respect to Part D pharmacy reimbursement; Information on standard Part D pharmacy contract terms and conditions relating to dispensing covered Part D drugs to 340B patients enrolled in Part D, including whether such 340B specific terms and conditions are common, and whether and how Part D plan sponsors determine when a claim is …

From the document’s text. It names 340B 3 times.
  • Has a part on 340B
  • Proposed rule

91 FR 43842Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Would require 340B covered entities to report Medicare Part D 340B claim data every quarter to a 340B repository run by the Centers for Medicare & Medicaid Services, for claims from January 1, 2027. Reporting was voluntary when this was proposed. Made final at 91 FR 70992.

Agency
Centers for Medicare & Medicaid Services
Published
16 July 2026
Comments closed
14 September 2026
Docket
CMS-1848-P
Where it names 340B: 91 FR 43842

… and the calculation of the Part D rebate amount in such instances; proposes a modification to the methodology finalized in the CY 2026 PFS final rule to account for 340B-eligible units for AIDS Drug Assistance Program (ADAP) enrollees for the applicable period beginning October 1, 2025; and proposes to require Medicare providers and …

From the document’s text. It names 340B 290 times.
  • Has a part on 340B
  • Proposed rule

91 FR 41734Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

Would pay hospitals for drugs bought under 340B at average sales price minus 33.4 percent for 2027, with minus 28 percent as an alternative, would exempt rural sole community hospitals, children's hospitals and the cancer hospitals paid outside the prospective payment system, would have hospitals mark 340B drugs with the claim modifier JG, and would raise the 340B remedy offset on other payments from 0.5 percent to 3 percent.

Agency
Centers for Medicare & Medicaid Services
Published
7 July 2026
Comments closed
31 August 2026
Docket
CMS-1850-P
Where it names 340B: 91 FR 41734

… outpatient quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. Under the proposed 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 3 percentage points. ASC Payment Update: For CYs 2019 through …

From the document’s text. It names 340B 413 times.
  • Has a part on 340B
  • Final rule

91 FR 3665Annual Civil Monetary Penalties Inflation Adjustment

Raises the penalty for each instance of overcharging a 340B covered entity from $7,034 to $7,217, as one row in the yearly inflation adjustment of the Department of Health and Human Services' civil penalties.

Agency
Health and Human Services Department
Published
28 January 2026
Where it names 340B: 91 FR 3665

… or conceals any record or report required. 56b(d)(1)(B)(vi).......... ...................... HRSA.......... Penalty for each instance of overcharging 2024 7,034 7,217 a 340B covered entity. 299c-3(d)................. ...................... AHRQ.......... Penalty for using or disclosing 2024 18,291 18,766 identifiable information obtained in …

From the document’s text. It names 340B once.
  • Has a part on 340B
  • Proposed rule

90 FR 60338Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

Would set up the GUARD Model, a Medicare Part D drug rebate test, and would leave out drug units covered under 340B. It says the agency cannot yet tell 340B claims apart in Part D data, so it assumed that 10 percent of units were 340B.

Agency
Centers for Medicare & Medicaid Services
Published
23 December 2025
Comments closed
23 February 2026
Docket
CMS-5546-P
Where it names 340B: 90 FR 60338

… We propose at Sec. 514.125(b) that the following drug units would be excluded from the GUARD Model: drug units for which payment is subject to an agreement under 340B. C. Proposed Model Test Design, Geographic Selection, and Beneficiary Population Section 1115A(b) of the Act gives the Secretary discretion in the design of models, …

From the document’s text. It names 340B 18 times.
  • Has a part on 340B
  • Proposed rule

90 FR 60244Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Would set up the GLOBE Model, a Medicare Part B drug rebate test, and would leave out units on claims billed with a 340B modifier. Made final at 91 FR 62936.

Agency
Centers for Medicare & Medicaid Services
Published
23 December 2025
Comments closed
23 February 2026
Docket
CMS-5545-P
Where it names 340B: 90 FR 60244

… applicable calendar quarter. This approach would ensure that units that are not included in the total number of billing units determined under 42 CFR 427.303, such as 340B units and units of discarded drugs, would also not be included in the total number of GLOBE Model billing units. We note that, because the total number of GLOBE Model …

From the document’s text. It names 340B 20 times.
  • Has a part on 340B
  • Final rule

90 FR 53448Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Rating; Hospital Price Transparency; and Notice of Closure of a Teaching Hospital and Opportunity To Apply for Available Slots

Keeps the 340B remedy offset on other hospital outpatient payments at 0.5 percent for 2026, where 2 percent had been proposed, and says a survey of what hospitals pay for drugs will open by early 2026.

Agency
Office of the Secretary
Published
25 November 2025
Comments closed
20 January 2026
Took effect
1 January 2026
Docket
CMS-1834-FC
Where it names 340B: 90 FR 53448

… quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. We note that under the final 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 0.5 percentage points. ASC Payment Update: For CYs 2019 through …

From the document’s text. It names 340B 270 times.
  • Has a part on 340B
  • Final rule

90 FR 49266Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Sets how Medicare removes Part D 340B units from drug inflation rebates starting January 1, 2026, and opens a voluntary 340B repository where covered entities may submit claim data.

Agency
Centers for Medicare & Medicaid Services
Published
5 November 2025
Took effect
1 January 2026
Docket
CMS-1832-F
Where it names 340B: 90 FR 49266

… Drug Inflation Rebate Program, this rule finalizes a methodology for removal of units for a Part D rebatable drug for which a manufacturer provides a discount under the 340B Program for the applicable period beginning October 1, 2025, as well as the establishment of a voluntary 340B data repository for Part D claims for testing purposes. …

From the document’s text. It names 340B 639 times.
  • Has a part on 340B
  • Proposed rule

90 FR 33476Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Overall Hospital Quality Star Ratings; and Hospital Price Transparency

Would raise the 340B remedy offset on other hospital outpatient payments from 0.5 percent to 2 percent for 2026, and announces a survey of what hospitals pay for drugs.

Agency
Office of the Secretary
Published
17 July 2025
Comments closed
15 September 2025
Docket
CMS-1834-P
Where it names 340B: 90 FR 33476

… quality reporting requirements by applying a reporting factor of 0.9805 to the OPPS payments and copayments for all applicable services. We note that under the proposed 340B remedy offset, payments for services at hospitals subject to the 340B remedy offset will be reduced by 2.0 percentage points. ASC Payment Update: For CYs 2019 through …

From the document’s text. It names 340B 113 times.
  • Has a part on 340B
  • Proposed rule

90 FR 32352Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

Would remove Part D 340B units from Medicare drug inflation rebates starting January 1, 2026, by matching claims, and would set up a voluntary 340B repository for covered entities' claim data.

Agency
Centers for Medicare & Medicaid Services
Published
16 July 2025
Comments closed
12 September 2025
Docket
CMS-1832-P
Where it names 340B: 90 FR 32352

… of a Part D rebate amount, and proposes a methodology for removal of units for a Part D rebatable drug for which a manufacturer provides a discount under the 340B Program, as well as the establishment of a 340B data repository for Part D claims. This rulemaking proposes to modify policies for the Shared Savings Program, which is …

From the document’s text. It names 340B 260 times.
  • Has a part on 340B
  • Presidential document

90 FR 16441Lowering Drug Prices by Once Again Putting Americans First

Executive Order 14273. Section 7 tells the Secretary of Health and Human Services to make future health center grants depend on offering insulin and injectable epinephrine to certain low-income patients at or below the price the health center paid under 340B, plus a minimal administration fee.

Agency
Executive Office of the President
Published
18 April 2025
Where it names 340B: 90 FR 16441

… establishing practices to make insulin and injectable epinephrine available at or below the discounted price paid by the health center grantee or sub-grantee under the 340B Prescription Drug Program (plus a minimal administration fee) to individuals with low incomes, as determined by the Secretary, who: (a) have a high cost-sharing …

From the document’s text. It names 340B once.

Mention 340B in passing

11 documents

The Federal Register is the authority. The sentence on each document is ours, written after reading it, and covers only what it does about 340B. Titles, agencies and dates are the Federal Register’s own. Read the document before you rely on it.

See something missing or out of date? Tell us.